Bruno Strul is listed as an executive officer and director on 18 SEC Form D filings by 4 issuers between Jan 2010 and May 2020: DFINE INC (San Jose, CA — industry reported as "Other" — 2010; $36.2M reported sold to 25 investors), MINERVA SURGICAL INC (Santa Clara, CA — other health care — 2010–2020; $26.2M reported sold to 26 investors), Iogyn, Inc. (Cupertino, CA — other health care — 2012; $5M reported sold to 1 investors) and ARQOS SURGICAL INC (Cupertino, CA — industry reported as "Other" — 2011; $1.53M reported sold to 12 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $68.9M sold in total.
Listed alongside Rodney Perkins (18 shared filings), Csaba Truckai (17 shared filings), David C. Auth (13 shared filings), David Clapper (13 shared filings), Robert Anderson (10 shared filings) and 13 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Bruno. Each name links to their own page.
2 of the issuers belong to the sponsor group Arqos (2 issuers, $6.53M reported sold, 2011–2012).
What this means A sponsor group is one team that sets up a new company for each deal. Arqos has 2 companies on file and $6.53M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 18 public filings for Bruno Strul and found 10 differences, 1 worth asking the sponsor about: Form D filed 68 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.